Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

Infection and Immunity

Volumn 74, Issue 8, 2006, Pages 4634-4643

  Santosuosso, Michael ^a   McCormick, Sarah ^a   Zhang, Xizhong ^a   Zganiacz, Anna ^a   Xing, Zhou ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ADENOVIRUS VECTOR EXPRESSING ANTIGEN 85A VACCINE; BCG VACCINE; GAMMA INTERFERON; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; LUNG ALVEOLUS CELL; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ACYLTRANSFERASES; ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENETIC VECTORS; HUMANS; IMMUNIZATION; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 33746632535     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00517-06     Document Type: Article

References (26)

1. Brewer, T. F. 2000. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31(Suppl. 3):S64-S67.
2. Buddle, B. M., D. N. Wedlock, N. A. Parlane, L. A. Corner, G. W. De Lisle, and M. A. Skinner. 2003. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect. Immun. 71:6411-6419.
3. Doherty, T. M., A. W. Olsen, L. van Pinxteren, and P. Andersen. 2002. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 70:3111-3121.
4. Ely, K. H., T. Cookenham, A. D. Roberts, and D. L. Woodland. 2006. Memory T cell populations in the lung airways are maintained by continual recruitment. J. Immunol. 176:537-543.
5. Feng, C. G., U. Palendira, C. Demangel, J. M. Spratt, A. S. Malin, and W. J. Britton. 2001. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Guerin against tuberculosis. Infect. Immun. 69:4174-4176.
6. Glyn Hewinson, R. 2005. TB vaccines for the world. Tuberculosis (Edinburgh) 85:1-6.
7. Goonetilleke, N. P., H. McShane, C. M. Hannan, R. J. Anderson, R. H. Brookes, and A. V. Hill. 2003. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol. 171:1602-1609.
8. Karonga Prevention Trial Group. 1996. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348:17-24.
9. McShane, H., A. A. Pathan, C. R. Sander, N. P. Goonetilleke, H. A. Fletcher, and A. V. Hill. 2005. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis (Edinburgh) 85:47-52.
10. McShane, H., A. A. Pathan, C. R. Sander, S. M. Keating, S. C. Gilbert, K. Huygen, H. A. Fletcher, and A. V. Hill. 2004. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10:1240-1244.
11. Pym, A. S., P. Brodin, L. Majlessi, R. Brosch, C. Demangel, A. Williams, K. E. Griffiths, G. Marchal, C. Leclerc, and S. T. Cole. 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9:533-539.
12. Rook, G. A., K. Dheda, and A. Zumla. 2005. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5:661-667.
13. Santosuosso, M., M. Divangahi, A. Zganiacz, and Z. Xing. 2002. Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer. Blood 99:1246-1252.
14. Santosuosso, M., S. McCormick, and Z. Xing. 2005. Adenoviral vectors for mucosal vaccination against infectious diseases. Viral Immunol. 18:283-291.
15. Santosuosso, M., J. Wang, and Z. Xing. 2005. The prospects of mucosal vaccination against pulmonary tuberculosis, p. 141-164. In L. Smithe (ed.), Focus on tuberculosis research. Nova Science Publishers Inc., Hauppauge, N.Y.
16. Santosuosso, M., X. Zhang, S. McCormick, J. Wang, M. Hitt, and Z. Xing. 2005. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 174:7986-7994.
17. Skinner, M. A., B. M. Buddle, D. N. Wedlock, D. Keen, G. W. de Lisle, R. E. Tascon, J. C. Ferraz, D. B. Lowrie, P. J. Cockle, H. M. Vordermeier, and R. G. Hewinson. 2003. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect. Immun. 71:4901-4907.
18. Vordermeier, H. M., K. Huygen, M. Singh, R. G. Hewinson, and Z. Xing. 2006. Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing mycobacterial antigen 85A and Mycobacterium bovis BCG. Infect. Immun. 74:1416-1418.
19. Vordermeier, H. M., S. G. Rhodes, G. Dean, N. Goonetilleke, K. Huygen, A. V. Hill, R. G. Hewinson, and S. C. Gilbert. 2004. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 112:461-470.
20. Wang, J., M. Santosuosso, P. Ngai, A. Zganiacz, and Z. Xing. 2004. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J. Immunol. 173:4590-4597.
21. Wang, J., L. Thorson, R. W. Stokes, M. Santosuosso, K. Huygen, A. Zganiacz, M. Hitt, and Z. Xing. 2004. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 173:6357-6365.
22. Wang, J., and Z. Xing. 2002. Tuberculosis vaccines: the past, present and future. Expert Rev. Vaccines 1:341-354.
23. Wiley, J. A., R. J. Hogan, D. L. Woodland, and A. G. Harmsen. 2001. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. J. Immunol. 167:3293-3299.
24. Woodland, D. L., and T. D. Randall. 2004. Anatomical features of anti-viral immunity in the respiratory tract. Semin. Immunol. 16:163-170.
25. World Health Organization. 2001. WHO vaccine-preventable diseases: monitoring system. 2000 global summary. World Health Organization, Geneva, Switzerland. [Online.] http://whqlibdoc.who.int/hq/2000/WHO_V&B_00.32 .pdf.
26. Xing, Z., M. Santosuosso, S. McCormick, T. C. Yang, J. Millar, M. Hitt, Y. Wan, J. Bramson, and H. M. Vordermeier. 2005. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr. Gene Ther. 5:485-492.